Notably, anti-TNF agents are not part of the standard therapeutic strategy for SLE, and currently, there is no universally accepted guideline or robust evidence supporting TB prophylaxis specifically in SLE. The gene discussed is TNF; the disease is systemic lupus erythematosus.